TARGET CAPITAL INVESTMENT

What TARGET CAPITAL INVESTMENT does

Target Capital Investment, operating as Target Capital Assets (TCA), is a privately held global investment management firm founded in 2011 (originally as a Micro, Small and Medium Enterprises Development loan scheme, later rebranded). It is incorporated as Target Capital Assets Limited with disclosed offices in Torrance, California (USA), Sunbury (UK), and Luxembourg, serving individuals, governments, pension funds, insurers, corporates, charities, and foundations across 80 countries. The firm reports $49bn in AUM as of 30 June 2023 and £78bn in real and digital assets under management.

The platform offers a broad multi-asset product surface spanning active equities, fixed income, multi-asset, private markets, quantitative strategies, real estate, infrastructure, real assets and natural resources, transportation, cryptocurrency/digital assets, and defined benefit pension solutions. Specialised investment programmes include a Medical Cannabis offering (cultivation, processing, R&D, private equity/expansion) and a Pharmaceutical programme (Starter Health, Growth Biotech, and Premium Innovation funds), with tiered minimums ranging from $1,500 to $250,000 and promised annual returns between 15% and 110%. Technology supporting investment selection includes the proprietary AgroSignal™ platform (combining satellite imagery, climate data, and production metrics for agricultural investments), the EnergyCore™ framework (oil and gas reserves, production efficiency, regulatory, and ESG assessment), and the ESG House Score built on 100+ internal and external data points. Distribution runs through a direct-to-consumer client portal with 24/7 live support, a 5-stage affiliate programme paying 3-7% instant deposit bonuses, and institutional/custodial relationships with Blockchain, Binance, Coinbase, and Cex for digital-asset execution and custody.

Revenue mechanics combine percentage-based brokerage fees on realised profits (10% for stocks/gold/oil/energy/transportation, 12% for crypto/FX/real estate/money market, 16% for cannabis), subscription-based investment programmes with advertised returns, asset-based share-class products (e.g., the 2026 Share Class at $50 per share), and affiliate referral commissions. The most recent disclosed AUM milestone ($49bn at June 2023), combined with continuous new product introduction (2026 Share Class, cannabis and pharma expansions) and geographic buildout (Luxembourg entity, APAC and Africa operating geographies), indicates an actively scaling franchise, though disclosure of revenue, headcount, and ownership structure is incomplete in public materials.

Name

TARGET CAPITAL INVESTMENT

Legal name

Target Capital Assets Limited

Website

https://targetcap-assets.com

Company type

Private

Founded year

2011

Operating status

Operating

Short description

Target Capital Investment (Target Capital Assets / TCA) is a privately held global investment manager founded in 2011, managing $49bn in AUM across equities, real estate, real assets, digital assets, cannabis, and pharmaceuticals for individual, corporate, pension, and institutional clients in 80 countries.

Ownership category

akta.pro rank

Product category

Investment Management

NAICS

Portfolio Management and Investment Advice (523940), Trust, Fiduciary, and Custody Activities (523991), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)

SIC

Investment Advice (6282)

akta.pro primary industry

Target-Risk / Risk-Profile Model Portfolios (FSAAAJAD)

akta.pro secondary industries

Target-Risk / Risk-Managed Allocation Funds (FSAAAEAG), Large-Cap Equity (Active) (FSAAAIAA)

Keywords

• Investment management services
• Asset management
• Wealth management
• ESG investing
• Pension fund management

Headquarters

HQ city

Torrance

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Management and Advisory Fees: Annual brokerage fees assessed on active trading accounts, with fee structures varying by asset class: Stocks 10%, Gold/Oil/Energy/Transportation 10%, Cannabis 16%, Crypto/Forex/Real Estate/Money Market 12% of realized profit.
2. Investment Fund Returns: Revenue generated from managed investment portfolios including pharmaceutical, medical cannabis, real assets, and other investment programs with specified ROI targets.
3. Affiliate Program Commissions: Instant bonus commissions paid to affiliates based on deposit amounts of referred users, ranging from 3% to 7% across 5 stages.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Target Capital Assets is a global investment management company that plans, saves, and invests on behalf of clients across multiple asset classes — active equities, fixed income, multi-asset, private markets, quantitative, real estate, real assets & natural resources, infrastructure, transportation, medical cannabis, pharmaceutical, and cryptocurrency/digital assets. It administers $49bn in client assets (as of 30 June 2023), offers defined benefit pension solutions, fiduciary management, and liquidity solutions, and distributes services through a digital client portal, affiliate network, and institutional sales channels.

Product overview

Target Capital Assets operates as a diversified global investment management platform offering multiple investment strategies and products. The platform provides core investment offerings across active equities, fixed income, multi-assets, private markets, quantitative investments, and real assets. Specialized investment programs include Medical Cannabis (cultivation, processing, R&D, private equity) and Pharmaceutical investments (Starter Health Fund, Growth Biotech Fund, Premium Innovation Fund). Real Estate services manage EUR 75-125 billion across 155+ investments in 20+ countries. The platform also offers cryptocurrency and digital assets, infrastructure, and transportation investments. Client services include Managed Portfolio Service (MPS) for multi-asset management, affiliate program, client portal with enrollment and account access, single investor services, corporate asset management, defined benefit pension schemes, and IPO/new issues access. All investment strategies incorporate ESG considerations through proprietary ESG House Scores. Fund products include the 2026 Share Class with $50 share price. The platform features blockchain-based payment tracking and a five-stage affiliate program.

Differentiator

Problem solved

Functional benefit

Products and services

• Active Equities Active investment management focusing on fundamental research to identify optimal equity investment opportunities globally.
• Fixed Income Fixed income investment solutions with ESG considerations embedded in the research process, combining valuation metrics with environmental, social, and governance factors.
• Multi Assets Multi-asset investment solutions incorporating ESG considerations with diversified exposure across multiple asset classes aligned to risk profiles.
• Private Markets Investment opportunities in private markets, including private equity and private credit, offering access to non-publicly traded assets.
• Quantitative Investments Quantitative investment strategies utilizing data-driven analytics and proprietary analytical frameworks for investment decisions.
• Real Estate Real estate investment platform managing EUR 75-125 billion across 155+ investments in 20+ countries, including development and buy-to-let properties for intermediaries, landlords, and developers globally.
• Real Assets & Natural Resources Investment platform covering agro-allied operations and oil & gas investments across upstream, midstream, and downstream sectors, utilizing AgroSignal™ and EnergyCore™ analytical frameworks.
• Medical Cannabis Investment Program Cannabis and life sciences investment program covering cultivation, processing, research, pharmaceutical-grade products, and international trade with compliance operations across Africa, Europe, North America, and Asia.
• Pharmaceutical Investment Program Structured pharmaceutical investment model supporting drug development, manufacturing, and healthcare solutions across generic medicines, specialty drugs, biotechnology, vaccines, and medical research.
• Crypto Currency and Digital Assets Cryptocurrency and digital asset investment solutions with a dedicated risk disclosure framework for digital token trading.
• Infrastructure Infrastructure investment opportunities as part of the Real Assets business segment.
• Transportations Transportation sector investments with ESG focus on environmentally friendly vehicles and insurance programs.
• Defined Benefit Solution Pension scheme investment solutions for matching income streams to liabilities with fiduciary management.
• Fiduciary Management Professional fiduciary management services for institutional clients and pension schemes.
• Liquidity Solutions Liquidity management solutions for institutional investors and wealth managers.
• Cultivation Projects (Medical Cannabis) Large-scale medical cannabis farming investments with modern greenhouse and indoor systems. Minimum $50,000; expected ROI 60%-80% annually; contract period 12-60 months.
• Processing & Manufacturing (Medical Cannabis) Investment in extraction, packaging, and pharmaceutical processing facilities for cannabis products including oils, capsules, and edibles. Minimum $100,000; expected ROI 80%-100% annually.
• Research & Development (Medical Cannabis) Clinical trials, product innovation, and medical research investments focused on pain management, mental health, and oncology support. Minimum $1,500; expected ROI 18%-25% annually.
• Private Equity & Expansion Fund (Medical Cannabis) Mergers, acquisitions, and international expansion project investments. Minimum $250,000; expected ROI 90%-110% annually; term 24-60 months.
• Starter Health Fund (Pharmaceutical) Pharmaceutical investment package focused on generic drugs and essential medicines. Minimum $5,000; ROI 15%-22% annually; term 12-24 months.
• Growth Biotech Fund (Pharmaceutical) Biotechnology and specialty medicines pharmaceutical investment. Minimum $15,000; ROI 20%-30% annually; term 24-36 months.
• Premium Innovation Fund (Pharmaceutical) Advanced research and global expansion pharmaceutical investment. Minimum $30,000; ROI 25%-40% annually; term 36-60 months.
• Managed Portfolio Service (MPS) Multi-asset investment management platform offering three strategies: passive management, combined active and passive, and sustainable ESG-focused approach with five multi-asset risk-aligned models.
• TCA Share Class 2026 Asset-backed investment product with $50 per share price, offering monthly or weekly interest rates (3.5%-10% monthly for $100-$99,999.99 investments; 2% weekly for 51 weeks for $100,000-$999,999.99). Available to new customers only.
• IPOs and New Issues Access to initial public offerings and new issue investments with no purchase commission, including exclusive IPO access and retail bond offerings.
• Sustainable Investing ESG-integrated sustainable investing platform encompassing climate change response, environmental sustainability, governance, social factors, and proprietary ESG House Scores drawing on 100+ data points.
• Responsible Investing Responsible investment approach integrating ESG factors into research, analysis, and decision-making with active engagement and AGM voting rights.
• Single Investor Services Income and growth investment strategies for individual investors including total return approaches, regional income mandates, and global dividend strategies.
• Corporate Asset Management Treasury operations and corporate financial asset management services with fiduciary commitment, asset allocation models, and international assurance capabilities.
• Defined Benefit Pension Schemes Service Pension scheme investment management solutions for defined benefit plans.

Quantifiable outcome

• $49bn assets under management as of June 2023
• +3 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and secondary.

• BlockchaincoreTechnology or IntegrationCustodian partner for trade execution and asset custody services on the TCA platform.
• BinancecoreTechnology or IntegrationCustodian and exchange partner for cryptocurrency trading and custody services.
• CoinbasecoreTechnology or IntegrationCustodian partner for cryptocurrency asset custody and trading infrastructure.
• CexsecondaryTechnology or IntegrationCryptocurrency exchange partner for trading services.
• 15+ Global Research InstitutionscoreStrategic or Co-development PartnerPartnerships with experienced agronomists, medical researchers, and compliance specialists for cannabis and life sciences program research and development.
• Regional Operational PartnerscoreStrategic or Co-development PartnerLocal execution partners across regions for real assets and natural resources investment operations.

Scale indicators17 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• abrdn: Global investment manager offering multi-asset, equities, fixed income, real estate, and ESG solutions to institutional and retail clients, including defined benefit pension clients — closely aligned with TCA's institutional multi-channel offering.
• Legal & General Investment Management: Major UK-based institutional asset manager with defined benefit, fixed income, real assets, and ESG capabilities serving pension schemes and insurers — highly comparable to TCA's defined-benefit solution and real-estate franchise.
• Invesco: Global investment manager offering equities, fixed income, multi-asset, real estate, and ETF products with a strong UK and European institutional pension presence, similar in breadth to TCA's product catalogue.
• Schroders: Large global asset manager with multi-asset, real estate, private assets, and sustainability franchises serving institutional and wholesale clients — directly comparable on multi-asset MPS-style and ESG offerings.
• Aviva Investors: UK-based global asset manager with multi-asset, real estate, infrastructure, and ESG offerings servicing pension schemes, insurers, and retail clients via a digital platform.
• M&G Investments: UK-headquartered global asset manager with active equities, fixed income, real estate, private markets, and ESG capabilities, serving pension funds, insurers, and retail clients through platform and intermediary channels.

Emerging players

• Baillie Gifford: Edinburgh-based global investment manager offering active equities and multi-asset strategies with strong ESG integration — comparable on long-term active management and ESG House Score-style differentiators.
• Jupiter Fund Management: UK-listed asset manager focused on multi-asset, fixed income, and ESG strategies distributed through intermediary and direct channels — similar market positioning to TCA's MPS-style offerings.
• WisdomTree: Global asset manager and ETF provider offering multi-asset, equities, and digital-asset exposure through digital platforms — comparable on the digital-channel, multi-asset, and cryptocurrency exposure side of TCA's platform.

Direct peers

• Hargreaves Lansdown: UK-headquartered direct-to-consumer investment platform offering funds, shares, SIPPs, and multi-asset portfolios to retail investors — directly comparable to TCA's client portal, self-serve enrollment, and affiliate-style distribution.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TARGET CAPITAL INVESTMENT